MENU

3D-printing a T1D-free future
Published on June 4, 2015

3D-printing technology has been providing hope to the medical community over the past few years with developments like the printing of prosthetic limbs, or even bone for skull fractures. Now, researchers have found a way to 3D-print a potential cure for type 1 diabetes, in the form of a protective structure for islet cells.

Share
Researchers discover that size matters…
Published on May 26, 2015

…the size and shape of capsules used in islet cell encapsulation therapy that is! Islet cell encapsulation is an exciting branch of type 1 diabetes research that is providing real potential for a future ‘cure’ for all people with type 1 diabetes. In this research, insulin-producing cells are protected by a ‘capsule’ that is implanted […]

Share

The Australian-first Type 1 Diabetes Clinical Research Resource Map (the Resource Map), published today by JDRF Australia, is a first ever snapshot analysis of the type 1 diabetes clinical research landscape in Australia. Incorporating data collected in interviews with leading Australian clinical researchers, the Resource Map has identified five key areas in the research development […]

Share
Could fish oil help T1D complications?
Published on May 12, 2015

Researchers from the US have found that taking fish oil every day was able to slow the development of T1D-related nerve damage in mice, and even reversed the damage that had already occurred. In the study, mice had their insulin-producing beta cells chemically destroyed to model type 1 diabetes, and were divided into different dietary […]

Share
New discovered pathway keeps immune system in check
Published on May 1, 2015

Discovery of an immune system molecule could help to boost the immunity of people with a predisposition to type 1 diabetes. JDRF researchers found that high levels of this molecule known as PEPITEM could restore normal immune T cell function and therefore reverse or stop the T1D autoimmune attack. These researchers identified that PEPITEM controls […]

Share
Australia’s largest study on the causes of T1D receives $8m boost
Published on April 27, 2015

JDRF Australia has today announced that a new $8 million partnership with The Leona M. and Harry B. Helmsley Charitable Trust, for investment into the Australian Type 1 Diabetes Clinical Research Network (T1DCRN), a JDRF Australia initiative. This partnership will support Environmental Determinants of Islet Autoimmunity (ENDIA), a ground-breaking study to help solve the mystery […]

Share
Learn More: JDRF Encapsulation Research
Published on April 20, 2015

JDRF’s research strategy focuses on a number of key areas that are most likely to deliver new therapies and treatments, and a cure, to people with type 1 diabetes in the most efficient and effective way in the short and long term. One of these key research areas is in the field of encapsulation – […]

Share
Nanoparticles re-educating the immune system
Published on April 17, 2015

JDRF partner Selecta is developing a new technology that could lead to a vaccine for T1D. In an article recently published in Proceedings of the National Academy of Sciences, researchers described the technology which uses nanoparticles to stop the autoimmune attack on insulin-producing beta cells in the pancreas.

Share
$8.5m investment in a T1D vaccine
Published on March 23, 2015

JDRF UK, Diabetes UK, and Tesco have announced $8.5 million of new funding for research into a type 1 diabetes (T1D) vaccine. The new funding provided by JDRF in conjunction with Diabetes UK and Tesco Supermarkets could produce the first working vaccines for T1D within the next generation. Four UK based projects will be funded:

Share